ACADIA PHARMACEUTICALS INC (ACAD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 400M 800M 1.2B Q3 '24: 929.2M Q4 '24: 957.8M Q1 '25: 996.3M Q2 '25: 1B Q3 '25: 1B Q4 '25: 1.1B Q1 '26: 1.1B Q2 '26: 1.1B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 250M 500M 750M Q1 '22: 481.5M Q2 '22: 500.7M Q3 '22: 501.3M Q4 '22: 507.1M Q1 '23: 511.3M Q2 '23: 537.2M Q3 '23: 605.7M Q4 '23: 684.8M Q1 '22 Q2 '22 Q3 '22 Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23

Operating Income TTM

0 90M 180M 270M Q3 '24: 112.2M Q4 '24: 230.8M Q1 '25: 234.9M Q2 '25: 236.8M Q3 '25: 240.9M Q4 '25: 104.8M Q1 '26: 80.9M Q2 '26: 86.4M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

0 150M 300M 450M Q3 '24: 128.5M Q4 '24: 226.5M Q1 '25: 228.9M Q2 '25: 222.2M Q3 '25: 261.2M Q4 '25: 391M Q1 '26: 375.6M Q2 '26: 380.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 35M 70M 105M Q3 '24: 77.9M Q4 '24: 81.8M Q1 '25: 79.3M Q2 '25: 81.8M Q3 '25: 84.6M Q4 '25: 89M Q1 '26: 93.4M Q2 '26: 101M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

-140M -70M 0 70M 140M 210M Q4 '22: -114M Q1 '23: -55.6M Q2 '23: -34.3M Q3 '23: -92.5M Q4 '24: 157.7M Q1 '25: 149M Q2 '25: 187.9M Q3 '25: 198.9M Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '24 Q1 '25 Q2 '25 Q3 '25

Free Cash Flow TTM

-210M -140M -70M 0 70M 140M 210M Q3 '21: -133.1M Q4 '21: -126.8M Q1 '22: -141.9M Q2 '22: -129.6M Q3 '22: -113.3M Q4 '22: -114M Q2 '25: 187.1M Q3 '25: 197.8M Q3 '21 Q4 '21 Q1 '22 Q2 '22 Q3 '22 Q4 '22 Q2 '25 Q3 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 60M 120M 180M Q1 '24: 166.6M Q2 '24: 166.2M Q3 '24: 166.2M Q1 '25: 167.7M Q2 '25: 168.7M Q3 '25: 170.7M Q1 '26: 172.7M Q2 '26: 172.9M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.80 1.60 2.40 Q3 '24: 0.78 Q4 '24: 1.36 Q1 '25: 1.37 Q2 '25: 1.33 Q3 '25: 1.55 Q4 '25: 2.30 Q1 '26: 2.21 Q2 '26: 2.23 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.